scholarly journals Resolution of exudative retinal detachment and regression of retinal macrocyst post-laser in Coats disease

2013 ◽  
pp. 37
Author(s):  
Zunaina Embong ◽  
Yusoff Munira ◽  
Yaakub Azhany
Keyword(s):  
Retinal Detachment ◽  
Exudative Retinal Detachment ◽  
Coats Disease

scholarly journals Coats’ Retinitis or Retinoblastoma in a 3-Year-Old Girl: A Case Report

Medicina ◽  
2012 ◽  
Vol 48 (4) ◽  
pp. 32
Author(s):  
Alvydas Paunksnis ◽  
Daiva Imbrasienė ◽  
Rasa Liutkevičienė ◽  
Kristina Rilienė ◽  
Evaldas Keleras ◽  
...  
Keyword(s):  
Retinal Detachment ◽  
Abnormal Development ◽  
Eye Drops ◽  
Exudative Retinal Detachment ◽  
Hard Exudates ◽  
Appropriate Treatment ◽  
Department Of Ophthalmology ◽  
Coats Disease ◽  
The Right

Coats’ disease is an idiopathic disorder defined by an abnormal development of retinal vessels with a progressive deposition of intraretinal or subretinal exudates, leading to exudative retinal detachment. The most difficult task is to differentiate Coats’ disease from retinoblastoma. We present a rare case of Coats’ disease diagnosed in a 3-year-old girl. From the age of 6 months, the girl was followed up 2 times a year at the Department of Ophthalmology, Hospital of Lithuanian University of Health Sciences, due to congenital convergent strabismus and refractive errors. At the age of 3.6 years, a routine examination of the fundus of the right eye revealed hard exudates, telangiectasia and tortuosity, gray color lesion below the optic nerve disc, submacular exudation in the inferior nasal part of the retina, and exudative retinal detachment, which extended from the 7-o’clock position to the 4-o’clock position. Before this examination, no abnormalities were found in the fundus of her both eyes. The girl was not treated with laser photocoagulation, cryocoagulation, or intravitreal injections, as the diagnosis of retinoblastoma could not be excluded; therefore, only eye drops were prescribed. In order to exclude the diagnosis of retinoblastoma, ultrasonography, magnetic resonance imaging, and computed tomography were carried out, and an appointment to see an ophthalmic oncologist was scheduled. Due to early and appropriate treatment, the progression of Coats’ disease in patients could be arrested. However, in some cases, when the diagnosis is ambiguous, it is better to follow up the patient and to treat only with eye drops.

scholarly journals Spontaneous reattachment of total exudative retinal detachment in Coats’ disease

2019 ◽  
Vol 12 (4) ◽  
pp. e229913 ◽  
Author(s):  
Anamika Patel ◽  
Bhavik Panchal ◽  
Avinash Pathengay
Keyword(s):  
Retinal Detachment ◽  
Exudative Retinal Detachment ◽  
Coats Disease

scholarly journals The detection of COAT’s disease at its early stage and management

2021 ◽  
Vol 11 (1) ◽  
pp. 16-21
Author(s):  
Rubina Shah
Keyword(s):  
Retinal Detachment ◽  
Early Stage ◽  
Genetic Disorders ◽  
Scleral Buckling ◽  
Abnormal Development ◽  
Diagnostic Tools ◽  
Exudative Retinal Detachment ◽  
Capillary Endothelial Cells ◽  
Coats Disease ◽  
Pars Plana

Coats disease is the potential leading cause of blindness which is an idiopathic disorder characterized by progressive deposition of intraretinal or subretinal exudates and abnormal development of retinal vasculatures known as telangiectasia that leads to exudative retinal detachment. The case shows unilateral involvement of the eye and primarily at an early age of 12 years. The cause of the disease is idiopathic and if associated with other genetic disorders emphasizes the deposition of a genetic component. The underlying histopathological problem is thought due to the abnormal permeability of capillary endothelial cells of the retina. The complications of long-standing disease may progress to total retinal detachment, leukocoria, painful Glaucoma and can be hard to differentiate from retinoblastoma. The diagnostic tools are indirect ophthalmoscopy, fluorescein angiography, CT scan, and MRI. The treatment depends on the closure of abnormal leaking vessels of the retina which is laser therapy and anti-VEGF at its early stage. The advanced stage requires surgical therapy such as scleral buckling, pars plana vitrectomy, and anterior vitrectomy for reattachment of the retina or pre retinal membrane. A careful selection therapy showed a 70% improvement in the clinical course of the disease

scholarly journals Coats disease with exudative retinal detachment simulating cysticercus cyst: misleading ultrasonography!

2018 ◽  
pp. bcr-2017-222975 ◽  
Author(s):  
Vineet Mutha ◽  
Sahil Agrawal ◽  
Parijat Chandra ◽  
Atul Kumar
Keyword(s):  
Retinal Detachment ◽  
Exudative Retinal Detachment ◽  
Coats Disease

scholarly journals The Management of “Coats' Response” in a Patient with X-Linked Retinitis Pigmentosa—A Case Report

ISRN Surgery ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-2 ◽  
Author(s):  
Shveta Bansal ◽  
Niladri Saha ◽  
W. H. Woon
Keyword(s):  
Visual Acuity ◽  
Case Report ◽  
Retinal Detachment ◽  
Retinitis Pigmentosa ◽  
Marked Reduction ◽  
Therapeutic Option ◽  
Exudative Retinal Detachment ◽  
Coats Disease

The management of exudative retinal detachment in Coats disease can be very difficult with variable results. A case is presented of a 12 year old boy who was diagnosed with X-linked retinitis pigmentosa with an associated “Coat's Response”. The patient had a marked reduction in his left visual acuity due to intragel and subhyaloid haemorrhage as well as exudative retinal detachment. This was managed successfully with vitrectomy and endolaser, resulting in clearance of the haemorrhage and flattening of the retina. In our experience endolaser should be considered as viable therapeutic option in the management of this condition.

Minimally Invasive 27-Gauge Vitrectomy for Coats’ Disease Retinal Detachment

2018 ◽  
Vol 2 (5) ◽  
pp. 312-315
Author(s):  
Ian C. Holmen ◽  
Zackery Oakey ◽  
Meisha Raven ◽  
Christopher P. Hartley ◽  
Michael Altaweel
Keyword(s):  
Retinal Detachment ◽  
Pars Plana Vitrectomy ◽  
Peripheral Vision ◽  
Subretinal Fluid ◽  
Subretinal Space ◽  
Exudative Retinal Detachment ◽  
Vascular Abnormalities ◽  
Coats Disease ◽  
Pars Plana ◽  
Endothelial Growth Factor

Purpose: To describe the use of 27-gauge pars plana vitrectomy in the management of Coats’ disease retinal detachment. Methods: Case report of a 10-year-old female presenting with exudative retinal detachment secondary to Coats’ disease. A two-port, 27-gauge pars plana vitrectomy, with one cannula in the subretinal space, was used to drain subretinal fluid. After resolution of the retinal detachment, a laser was directed to vascular abnormalities, and intravitreal antivascular endothelial growth factor was administered. Results: At 1 year follow-up, her retinal detachment remained resolved, peripheral vision had improved, and visual acuity had stabilized. Conclusions: A 27-gauge vitrectomy can be used successfully in the treatment of exudative Coats’ detachment. The use of valved trocars allows control of intraocular pressure and simultaneous controlled extrusion of subretinal fluid, decreasing the risk of retinal incarceration.

Adjunctive Intravitreal Triamcinolone Acetonide for Exudative Retinal Detachment in Coats Disease

2021 ◽  
pp. 247412642110189
Author(s):  
Wael A. Alsakran ◽  
Sawsan R. Nowilaty ◽  
Nicola G. Ghazi ◽  
Yahya Alzahrani ◽  
Abdulrahman AlZaid ◽  
...  
Keyword(s):  
Retinal Detachment ◽  
Triamcinolone Acetonide ◽  
Disease Stage ◽  
Exudative Retinal Detachment ◽  
Surgical Drainage ◽  
Intravitreal Triamcinolone ◽  
Ablative Therapy ◽  
Intravitreal Triamcinolone Acetonide ◽  
Coats Disease

Purpose: This work aims to assess the value of intravitreal triamcinolone acetonide (IVTA) as an adjunctive therapy in advanced Coats disease with exudative retinal detachment (ERD). Methods: A retrospective review was conducted of patients with Coats disease stage 3 or higher who received IVTA to decrease subretinal fluid (SRF), facilitate retinal ablative therapy, and avoid surgical drainage. Primary outcomes were SRF resolution and avoidance of surgical SRF drainage. Results: Seventeen eyes of 17 patients (mean, [SD] age, 3.9 [3.4] years) met the inclusion criteria. ERD configuration was bullous in 7 and shallow in 10 eyes. Following a single IVTA injection, ablative therapy was achieved after a mean (SD) of 2.1 (3.0) weeks. Complete SRF resolution was observed in 13 eyes (76.4%) after a mean of 1.3 IVTA injections and a mean of 2 (SD, 1.27) laser sessions, and none of these eyes required SRF drainage up to last follow-up (mean [SD], 50.5 [26.24] months). In 4 eyes with bullous ERD at presentation, SRF persisted ( P = .015) despite additional measures including surgical drainage. Final visual acuity ranged from 20/100 to no light perception. Cataract developed in 12 of the 17 eyes (70.5%). None developed an increase in intraocular pressure at final follow-up. Conclusions: IVTA injection can be a helpful adjunctive modality to address SRF in advanced Coats disease. It may obviate the need to surgically drain SRF to effectively treat the condition, particularly when the ERD is not highly bullous.

Sign in / Sign up

Export Citation Format

Share Document